Article
Subclonal β-catenin/YAP signaling heterogeneity accelerates ovarian cancer metastasis through a senescence-associated secretory phenotype.
Cell death & disease - 23 Apr 2026
To Sally K Y, Yang Yibin, Shi Zeyu, Fung Katie S W, Lai Sook Ling, Li Joshua J X, Ip Philip P C, Wong Alice S T
Abstract excerpt
Intratumoral heterogeneity in metastatic cancers complicates effective treatment, as distinct tumor subclones display varying drug sensitivities and metastatic capabilities, interacting through mechanisms that remain poorly understood. In this study, we utilized an isogenic ovarian cancer cell pair distinguished by differential β-catenin signaling: non-metastatic (NM) cells with low β-catenin and highly...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
